Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2018/05/014024
CTRI/2018/05/014024
Completed
未知

Acetylcysteine supplementation for the prevention of postoperative liver dysfunction in on-pump cardiac surgery

Dr Ram Manohar Lohia institute of Medical Sciences Lucknow0 sites66 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Dr Ram Manohar Lohia institute of Medical Sciences Lucknow
Enrollment
66
Status
Completed
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
February 12, 2019
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Dr Ram Manohar Lohia institute of Medical Sciences Lucknow

Eligibility Criteria

Inclusion Criteria

  • •Expected prolonged CPB duration ( \>2 hours)
  • •Valve surgery, CABG and CABG with valve on\-pump
  • •Written informed consent

Exclusion Criteria

  • •Age \<18 years or \>65 years
  • •Known allergy to N\-Acetylcystine
  • •Emergency cardiac surgery
  • •Known blood borne infectious disease
  • •Existing deranged LFT
  • •End stage renal disease
  • •Planned off\-pump cardiac surgery
  • •No written informed consent

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
acetylcysteine as a Preventive Measure for Contrast Induced Nephropathy in Intensive Care Patients with Renal InsufficiencyRenal insufficiencyUrological and Genital Diseases
ISRCTN43635237Academic Medical Centre (AMC) (Netherlands)246
Active, not recruiting
Not Applicable
Acetytilcysteine Versus placebo for the prevention of Acute Reduction in Renal function after primary Angioplasty (NoVARA) - NoVARApatient with ST elevation myocardial acute infarctionMedDRA version: 9.1Level: SOCClassification code 10007541
EUCTR2010-022952-22-ITAZIENDA OSPEDALIERA MAGGIORE DELLA CARITA` DI NOVARA
Not yet recruiting
Phase 4
acetylcysteine to improve neurological outcomes in neonates with hypoxic ischemic encephalopathyHealth Condition 1: P039- Newborn affected by complication of labor and delivery, unspecified
CTRI/2021/03/031798Jawaharlal Institute of Postgraduate Medical Education and Research
Completed
Phase 2
Adjuvant N Acetylcysteine for Post Traumatuic Stress Disorder
ACTRN12618001784202Austin Health105
Recruiting
Phase 3
Acetylcysteine for the Prevention of Liver Injury in Covid-19 PatientsK72.0Condition 1: COVID-19 pneumonia. Condition 2: Acute liver injury.Pneumonia due to SARS-associated coronavirusAcute and subacute hepatic failureJ12.81
IRCT20210726051995N1Artesh University of Medical Sciences88